DETAILS, FICTION AND WHO MAKES COPYRIGHT SEMAGLUTIDE

In March 2025, the company declared new strategies for the immediate-to-customer supplying of its Wegovy weight loss drug. The company founded a new pharmacy, called NovoCare, which would demand consumers $499 a month for access to the drug, fewer than 50 % the expense of the drug via other pharmaceutical distribution networks.[53]Knowledge the pro